|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.044 AUD | 0.00% |
|
+2.33% | -29.03% |
| Mar. 25 | Transcript : Prescient Therapeutics Limited - Special Call | |
| Feb. 23 | Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Prescient Therapeutics Limited announced the appointment of Ms, Melanie Leydin as Company Secretary of the company effective this day. Melanie is a Chartered Accountant with 20 years' experience and an extensive background with ASX Listed entities. She is Principal of Leydin Freyer Corp.
Pty Ltd. The company advised that Mr. Sean Henbury has tendered his resignation as Company Secretary effective this day.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.03% | 23.5M | |
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +45.66% | 40.65B | |
| -10.72% | 27.12B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
PRESCIENT THERAPEUTICS LIMITED 
